Trupanion (TRUP) Aandelenoverzicht
Trupanion, Inc. biedt samen met haar dochterondernemingen medische verzekeringen voor honden en katten op abonnementsbasis in de Verenigde Staten, Canada, continentaal Europa en Australië. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 1/6 |
| Prestaties in het verleden | 2/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
TRUP Community Fair Values
Create NarrativeSee what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Trupanion, Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$21.98 |
| 52 Week Hoogtepunt | US$57.89 |
| 52 Week Laag | US$21.16 |
| Bèta | 1.49 |
| 1 maand verandering | -19.96% |
| 3 maanden verandering | -17.68% |
| 1 Jaar Verandering | -53.99% |
| 3 jaar verandering | 3.29% |
| 5 jaar verandering | -74.94% |
| Verandering sinds IPO | 92.81% |
Recent nieuws en updates
Narratiefupdate • May 13
TRUP: Recalibrated Expectations And Higher Future P/E Will Support Long-Term Repricing
Analysts have lowered their fair value estimate for Trupanion from $63.00 to $52.00, citing updated price targets from several firms along with adjustments to discount rates, revenue growth, profit margin assumptions, and the stock's future P/E multiple. Analyst Commentary Recent Street research on Trupanion has centered on revised price targets that reflect updated assumptions for growth, margins, and valuation multiples.
Narratiefupdate • Apr 22
TRUP: Clustered Price Cuts And P/E Reset Will Shape Future Returns
Trupanion's updated analyst price target has been reduced by a mid single digit dollar amount, with analysts pointing to recently lowered targets from several firms, alongside only modest tweaks to long term revenue growth, profit margin and future P/E assumptions. Analyst Commentary Recent Street research on Trupanion has centered on a series of price target reductions, with cuts ranging from low single digit dollar amounts up to a $15 move.Narratiefupdate • Apr 08
TRUP: Revised P/E And Margin Assumptions Will Support Future Earnings Power
Trupanion's updated analyst price target has shifted from $42.00 to $31.00 as analysts factor in different assumptions for future revenue growth, profitability and P/E expectations following several recent target cuts across the Street. Analyst Commentary Recent Street research on Trupanion has centered on a series of lower price targets, with several bearish analysts trimming their expectations within a relatively short time frame.Recent updates
Narratiefupdate • May 13
TRUP: Recalibrated Expectations And Higher Future P/E Will Support Long-Term Repricing
Analysts have lowered their fair value estimate for Trupanion from $63.00 to $52.00, citing updated price targets from several firms along with adjustments to discount rates, revenue growth, profit margin assumptions, and the stock's future P/E multiple. Analyst Commentary Recent Street research on Trupanion has centered on revised price targets that reflect updated assumptions for growth, margins, and valuation multiples.Narratiefupdate • Apr 22
TRUP: Clustered Price Cuts And P/E Reset Will Shape Future Returns
Trupanion's updated analyst price target has been reduced by a mid single digit dollar amount, with analysts pointing to recently lowered targets from several firms, alongside only modest tweaks to long term revenue growth, profit margin and future P/E assumptions. Analyst Commentary Recent Street research on Trupanion has centered on a series of price target reductions, with cuts ranging from low single digit dollar amounts up to a $15 move.Narratiefupdate • Apr 08
TRUP: Revised P/E And Margin Assumptions Will Support Future Earnings Power
Trupanion's updated analyst price target has shifted from $42.00 to $31.00 as analysts factor in different assumptions for future revenue growth, profitability and P/E expectations following several recent target cuts across the Street. Analyst Commentary Recent Street research on Trupanion has centered on a series of lower price targets, with several bearish analysts trimming their expectations within a relatively short time frame.
Narratiefupdate • Mar 25
TRUP: Rebased P/E Expectations Will Support Long Term Upside Potential
Narrative Update on Trupanion The analyst price target for Trupanion has been reduced by a combined $26, as several firms revisited their models and pricing assumptions. This led to a lower implied future P/E while keeping the fair value estimate steady at $46.25.Narratiefupdate • Mar 10
TRUP: Reset Expectations And Higher Future P/E Will Drive Long-Term Repricing
Trupanion's updated $63.0 analyst price target reflects modestly tempered expectations for revenue growth and profit margin, with analysts citing recent target reductions from several firms as they reassess the stock's risk and return trade off. Analyst Commentary Recent Street research on Trupanion clusters around lower price targets, but the tone is not uniformly negative.Narratiefupdate • Feb 24
TRUP: Long Term Profitability Assumptions Will Support Future Upside Potential
Analysts have reduced their Trupanion price targets by approximately $10 to $46.25, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions following recent research updates from multiple firms. Analyst Commentary Recent research updates on Trupanion point to a mix of optimism about the long term opportunity and caution about the execution and valuation risks in the near term.Narratiefupdate • Feb 09
TRUP: Higher Future P/E Assumptions Will Support A Stronger Long-Term Repricing
Analysts have reduced their Trupanion price target by about $4 to US$63, citing updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E as the key drivers of the change. Analyst Commentary Bullish analysts are refining their views on Trupanion as they revisit key valuation inputs such as fair value estimates, discount rates, revenue assumptions, profit margins and future P/E levels.Narratiefupdate • Jan 25
TRUP: Revised P/E Assumptions Will Support Long Term Earnings Power
Analysts have reduced their price targets on Trupanion by $8, citing updated assumptions for revenue growth, profit margin and future P/E, which modestly adjust the risk and return profile they see for the stock. Analyst Commentary Bearish analysts cutting their price targets by $8 are signaling a more cautious stance on Trupanion, driven by updated assumptions for revenue growth, profit margin and future P/E.Narratiefupdate • Jan 11
TRUP: Future Margin Gains And Share Discipline Will Support Long Term Earnings Power
Analysts are maintaining a US$42.00 price target for Trupanion, with small adjustments to revenue growth, profit margin assumptions and a lower future P/E helping to fine tune their outlook rather than reset it. What's in the News Trupanion reported that, between July 1 and September 30, 2025, it did not repurchase any shares under its existing program and has completed total buybacks of 95,021 shares for US$5.75 million, representing 0.23% of shares under the buyback announced on April 30, 2021 (company filing).Narratiefupdate • Dec 27
TRUP: Future Margin Expansion Will Support Strengthening Long Term Earnings Power
Analysts have modestly maintained their price target on Trupanion at approximately $42.00, citing slightly stronger expectations for revenue growth, incremental profit margin improvement, and a marginally lower future price to earnings multiple that together support the current valuation stance. What's in the News Updated full year 2025 guidance now calls for total revenue of $1.433 billion to $1.439 billion and subscription revenue of $986 million to $989 million, implying roughly 15% year over year subscription growth at the midpoint (company guidance).Narratiefupdate • Dec 12
TRUP: Future Margin Recovery Will Support Strengthening Long Term Earnings Power
Analysts have modestly reduced their price target on Trupanion from 45.00 dollars to 42.00 dollars. This reflects more conservative assumptions for revenue growth, profit margins, and valuation multiples, despite a largely unchanged risk outlook.Narratiefupdate • Aug 10
Increasing Pet Ownership And Data Analytics Will Expand Market
The consensus price target for Trupanion has increased to $59.67 as analysts assign a higher future P/E multiple despite a modest decline in net profit margin, signaling greater optimism about its growth prospects. Valuation Changes Summary of Valuation Changes for Trupanion The Consensus Analyst Price Target has significantly risen from $53.00 to $59.67.Nieuw narratief • May 27
Global Expansion And Pricing Precision Will Shape Pet Markets
Enhanced pricing strategies, technology upgrades, and disciplined underwriting are driving margin expansion, higher operational efficiency, and more sustainable long-term earnings.Analyseartikel • May 13
Trupanion, Inc. (NASDAQ:TRUP) Looks Just Right With A 26% Price Jump
Trupanion, Inc. ( NASDAQ:TRUP ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...Analyseartikel • Feb 16
There's Reason For Concern Over Trupanion, Inc.'s (NASDAQ:TRUP) Price
When close to half the companies in the Insurance industry in the United States have price-to-sales ratios (or "P/S...Seeking Alpha • Dec 13
Trupanion: High Costs And Price Hikes Are Reasons To Avoid This Pet Insurer
Summary Trupanion's Q3'24 revenue grew 15% YoY to $327.5M, driven mainly by price hikes, but EPS missed estimates by $0.46. Subscription adjusted operating income surged 66% to $30.8M, improving margins, but new pet growth deceleration raises concerns. Expansion into Germany and Switzerland offers growth opportunities, but North American profitability and competitive pressures remain critical challenges. Trupanion faces risks from unsustainable price hikes, growing veterinary inflation, and higher acquisition costs. Its strategy of ramping up pet acquisition spending could pressure short-term profitability without guaranteeing long-term growth. Despite growth prospects in the pet insurance market, Trupanion’s high valuation, with an expected 7% revenue growth in 2025, makes it an expensive investment. Read the full article on Seeking AlphaAnalyseartikel • Oct 25
Revenues Tell The Story For Trupanion, Inc. (NASDAQ:TRUP) As Its Stock Soars 25%
Trupanion, Inc. ( NASDAQ:TRUP ) shares have continued their recent momentum with a 25% gain in the last month alone...Seeking Alpha • Sep 24
Trupanion: Great Business, But It Is Time To Cash Out (Rating Downgrade)
Summary Trupanion's stock surged over 60% since my June 2024 buy rating. Trupanion's Q2 results show strong revenue and subscription growth, with free cash flow turning positive, indicating a sustainable business model. Price hikes are essential due to rising veterinary costs and increasing anxiety claims in pets, which could impact long-term profitability if not managed. Shares are no longer a buy, and I reiterate my $40 price target with a hold rating now. Read the full article on Seeking AlphaAnalyseartikel • Aug 11
Trupanion, Inc. (NASDAQ:TRUP) Just Reported And Analysts Have Been Lifting Their Price Targets
It's been a pretty great week for Trupanion, Inc. ( NASDAQ:TRUP ) shareholders, with its shares surging 14% to US$38.30...Analyseartikel • Jul 31
A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb
Trupanion, Inc. ( NASDAQ:TRUP ) shares have continued their recent momentum with a 27% gain in the last month alone...Seeking Alpha • Jun 13
Trupanion: Growth First, Profitability Second
Summary Trupanion is a global pet insurance company. Trupanion may be headed for profitability, with the new CEO emphasizing efficiency and free cash flow. The company offers pet insurance through subscriptions, focusing on growth first and profits later. Shares are a buy with a price target of $40. Read the full article on Seeking AlphaAnalyseartikel • Feb 16
A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb
Despite an already strong run, Trupanion, Inc. ( NASDAQ:TRUP ) shares have been powering on, with a gain of 27% in the...Seeking Alpha • Feb 02
Trupanion: After All This Time, No Profits
Summary Pet insurance industry has seen significant growth due to the rising trend of millennials and Gen Z preferring pets over having children. Trupanion, a pet insurance company, has experienced wild revenue growth but struggles with increasing costs and negative margins. The company's balance sheet is not heavily burdened with liabilities, but profitability hinges on stabilizing operating expenses and addressing veterinary price hikes. Read the full article on Seeking AlphaAnalyseartikel • Dec 18
A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb
Trupanion, Inc. ( NASDAQ:TRUP ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...Analyseartikel • Apr 18
What You Can Learn From Trupanion, Inc.'s (NASDAQ:TRUP) P/SAfter Its 35% Share Price Crash
The Trupanion, Inc. ( NASDAQ:TRUP ) share price has fared very poorly over the last month, falling by a substantial...Rendement voor aandeelhouders
| TRUP | US Insurance | US Markt | |
|---|---|---|---|
| 7D | -0.5% | -0.6% | 1.2% |
| 1Y | -54.0% | -6.7% | 28.7% |
Rendement versus industrie: TRUP presteerde slechter dan de US Insurance -sector, die het afgelopen jaar een rendement van -6.7 % opleverde.
Rendement versus markt: TRUP presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 28.7 % opleverde.
Prijsvolatiliteit
| TRUP volatility | |
|---|---|
| TRUP Average Weekly Movement | 6.5% |
| Insurance Industry Average Movement | 4.4% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: TRUP heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van TRUP is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2006 | 1,121 | Margi Tooth | www.trupanion.com |
Trupanion, Inc. biedt, samen met haar dochterondernemingen, medische verzekeringen voor honden en katten op abonnementsbasis in de Verenigde Staten, Canada, continentaal Europa en Australië. Het bedrijf opereert in twee segmenten, Subscription Business en Other Business. Het bedient huisdiereigenaren en dierenartsen.
Trupanion, Inc. Samenvatting
| TRUP fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$958.78m |
| Inkomsten(TTM) | US$25.80m |
| Inkomsten(TTM) | US$1.48b |
37.2x
Koers/Winstverhouding0.6x
P/S-verhoudingIs TRUP overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| TRUP resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$1.48b |
| Kosten van inkomsten | US$1.15b |
| Brutowinst | US$330.92m |
| Overige uitgaven | US$305.12m |
| Inkomsten | US$25.80m |
Laatst gerapporteerde inkomsten
Mar 31, 2026
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 0.59 |
| Brutomarge | 22.34% |
| Nettowinstmarge | 1.74% |
| Schuld/Eigen Vermogen Verhouding | 27.7% |
Hoe presteerde TRUP op de lange termijn?
Bekijk historische prestaties en vergelijkingBedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/26 05:49 |
| Aandelenkoers aan het einde van de dag | 2026/05/22 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Trupanion, Inc. wordt gevolgd door 16 analisten. 5 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Christopher Merwin | Barclays |
| Joshua Shanker | BofA Global Research |
| Ryan Tunis | Cantor Fitzgerald & Co. |